Beckman Coulter Developing NSCLC Companion Dx for Transgene

The test under development will be used in an upcoming clinical trial to determine which patients may be suitable for treatment with an immunotherapy candidate for non-small cell lung cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories